
Eric Olson
Examiner (ID: 15792, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1623, 1693 |
| Total Applications | 1700 |
| Issued Applications | 960 |
| Pending Applications | 118 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18108018
[patent_doc_number] => 20230000898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/852453
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852453 | COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES | Jun 28, 2022 | Abandoned |
Array
(
[id] => 20158200
[patent_doc_number] => 12384812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Proton activated atomic medicine
[patent_app_type] => utility
[patent_app_number] => 17/850467
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14665
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850467 | Proton activated atomic medicine | Jun 26, 2022 | Issued |
Array
(
[id] => 17851812
[patent_doc_number] => 20220281854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMBINATION THERAPY FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/751153
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751153 | COMBINATION THERAPY FOR TREATING CANCER | May 22, 2022 | Abandoned |
Array
(
[id] => 17790445
[patent_doc_number] => 20220249536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ANTIBODY DRUG CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/730924
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730924 | Antibody drug conjugates | Apr 26, 2022 | Issued |
Array
(
[id] => 17807418
[patent_doc_number] => 20220259253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => CD73 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/722513
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 1087
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722513 | CD73 INHIBITORS | Apr 17, 2022 | Abandoned |
Array
(
[id] => 19650016
[patent_doc_number] => 12171776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Methods for treatment and prophylaxis of HIV and AIDS
[patent_app_type] => utility
[patent_app_number] => 17/658547
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9805
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/658547 | Methods for treatment and prophylaxis of HIV and AIDS | Apr 7, 2022 | Issued |
Array
(
[id] => 18109631
[patent_doc_number] => 20230002511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => HIGH-VISCOSITY LITHIUM CARBOXYMETHYL CELLULOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/681971
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681971 | High-viscosity lithium carboxymethyl cellulose and preparation method therefor and application thereof | Feb 27, 2022 | Issued |
Array
(
[id] => 17670944
[patent_doc_number] => 20220184111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
[patent_app_type] => utility
[patent_app_number] => 17/682655
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682655 | METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY | Feb 27, 2022 | Abandoned |
Array
(
[id] => 17687687
[patent_doc_number] => 20220194979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR PREPARING DELPHINIUM ACYLATED ANTHOCYANIN
[patent_app_type] => utility
[patent_app_number] => 17/674860
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674860 | Method for preparing delphinium acylated anthocyanin | Feb 17, 2022 | Issued |
Array
(
[id] => 18091303
[patent_doc_number] => 20220409644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/674032
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674032 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | Feb 16, 2022 | Abandoned |
Array
(
[id] => 17642270
[patent_doc_number] => 20220170008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/674177
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674177 | POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME | Feb 16, 2022 | Pending |
Array
(
[id] => 19441229
[patent_doc_number] => 12091470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Use of poly alpha-1,3-glucan ethers as viscosity modifiers
[patent_app_type] => utility
[patent_app_number] => 17/667707
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36004
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667707 | Use of poly alpha-1,3-glucan ethers as viscosity modifiers | Feb 8, 2022 | Issued |
Array
(
[id] => 17865361
[patent_doc_number] => 20220288096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/588507
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588507 | COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER | Jan 30, 2022 | Abandoned |
Array
(
[id] => 20192217
[patent_doc_number] => 20250268927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => SYNBIOTIC TREATMENT REGIMENS
[patent_app_type] => utility
[patent_app_number] => 18/261012
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261012
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261012 | SYNBIOTIC TREATMENT REGIMENS | Jan 11, 2022 | Pending |
Array
(
[id] => 17945836
[patent_doc_number] => 20220332853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => MANUFACTURING PROCESS FOR CYCLODEXTRIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/555286
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555286 | MANUFACTURING PROCESS FOR CYCLODEXTRIN DERIVATIVES | Dec 16, 2021 | Abandoned |
Array
(
[id] => 17748114
[patent_doc_number] => 20220226317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527087
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527087
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527087 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Abandoned |
Array
(
[id] => 17748113
[patent_doc_number] => 20220226316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527085
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527085
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527085 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Abandoned |
Array
(
[id] => 17748112
[patent_doc_number] => 20220226315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SYNERGISTIC COMBINATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/527084
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527084 | SYNERGISTIC COMBINATIONS AND METHODS OF USE | Nov 14, 2021 | Abandoned |
Array
(
[id] => 17414018
[patent_doc_number] => 20220048922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => COMPOUNDS TARGETING PRMT5
[patent_app_type] => utility
[patent_app_number] => 17/452689
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17452689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/452689 | COMPOUNDS TARGETING PRMT5 | Oct 27, 2021 | Abandoned |
Array
(
[id] => 17412712
[patent_doc_number] => 20220047616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Method and Compositions for Treating HTLV-1 Virus Infection
[patent_app_type] => utility
[patent_app_number] => 17/512183
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/512183 | Method and Compositions for Treating HTLV-1 Virus Infection | Oct 26, 2021 | Abandoned |